{"id":"W1989556851","doi":"10.1517/13543770903059125","title":"The search for new COX-2 inhibitors: a review of 2002 – 2008 patents","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Merck Canada; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Naproxen; Valdecoxib; Celecoxib; Medicine; Ibuprofen; Pharmacology; Inflammation; Cyclooxygenase; Nabumetone; Aspirin; Etoricoxib; Nonsteroidal; Chemistry; Enzyme; Rofecoxib; Internal medicine; Biochemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005654444,0.000990247,0.001415107,0.004051274,0.0002784392,0.0008630234,0.0008635869,0.0008962286,0.007669982],"category_scores_gemma":[0.00086089,0.0003176877,0.0006458634,0.00461293,0.0002676747,0.001445955,0.0004371291,0.0008794495,0.002801797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008698654,"about_ca_system_score_gemma":0.001254633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001015904,"about_ca_topic_score_gemma":0.002930473,"domain_scores_codex":[0.9997639,0.00003064461,0.00003551642,0.00003611589,0.0001127175,0.00002112703],"domain_scores_gemma":[0.9996498,0.0001086895,0.00009148942,0.000007459984,0.0001092083,0.00003336612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001175676,0.0000835235,0.0001560655,0.02335889,0.0001299099,0.0005179402,0.00006380517,0.0003363813,0.00211194,0.001568173,0.05024028,0.9213155],"study_design_scores_gemma":[0.00006849528,0.0001928993,0.001249094,0.006640683,0.0003119779,0.001731032,0.00007120697,0.0001215437,0.0006922183,0.0009618573,0.9879382,0.000020741],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003245483,0.9968808,0.000107099,0.0004118642,0.0002307347,0.00001366957,0.00004819615,0.000008069278,0.001975014],"genre_scores_gemma":[0.001033253,0.9971239,0.0002555464,0.00032391,0.0002315618,0.00001029257,0.00009153367,0.000001456836,0.0009285542],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007669982,"threshold_uncertainty_score":0.02565867,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1324520550520304,"score_gpt":0.4087917491154659,"score_spread":0.2763396940634354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}